| BIAsp 30 (biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk |
NCT01542424: An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus |
|
|
| Completed | N/A | 1889 | RoW | biphasic insulin aspart 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 12/06 | 12/06 | | |
NCT01536613: Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 |
|
|
| Completed | N/A | 5346 | RoW | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 02/07 | 02/07 | | |
NCT00665093: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 1569 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/08 | 01/08 | | |
NCT00671008: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes |
|
|
| Completed | N/A | 400 | RoW | biphasic insulin aspart 30, NovoMix® 30, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/08 | 09/08 | | |
NCT00675493: Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30 |
|
|
| Completed | N/A | 942 | Europe | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/09 | 01/09 | | |
NCT00698269: An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment |
|
|
| Completed | N/A | 5926 | RoW | insulin detemir, Levemir®, biphasic insulin aspart 30, insulin aspart | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
SAFE, NCT00789711: An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes |
|
|
| Completed | N/A | 3131 | RoW | biphasic insulin aspart 30, NovoMix® 30, BIASP, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 08/09 | 08/09 | | |
EFFECTIVE, NCT00699179: Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes |
|
|
| Completed | N/A | 2308 | RoW | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/09 | 09/09 | | |
UPGRADE, NCT00737776: Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes |
|
|
| Completed | N/A | 1068 | RoW | biphasic insulin aspart 30, NovoMix® 30, NovoLog® Mix 70/30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 01/10 | 01/10 | | |
